Insights On Manufacturing Logistics
-
Annex 21 – Are We On Track And Is There An Impact?
5/6/2024
What does Annex 21 entail, what makes the process of meeting the requirements so complex and time-consuming, and has Annex 21 inadvertently created additional barriers to supply.
-
Four Common Types Of Cryogenic Studies For Advanced Therapies
5/6/2024
Learn why cryopreservation studies are so critical and how biopharmaceutical manufacturers can more easily navigate the complexities of this process.
-
Accelerating SARS-CoV-2 Immunotherapy Speed To Clinic
4/26/2024
A clinical-stage biotherapeutics company developing a COVID-19 immunotherapy searched for a solution to the difficulties it faced in scaling up its manufacturing operations due to limited resources.
-
Innovative Preservation Solutions For Cell Therapy
4/18/2024
The low efficiency and poor biocompatibility of conventional preservatives hinder successful cell preservation. Explore solutions to enhance the stability and post-thaw viability of cell therapy products.
-
Unlocking The Potential Of Your Sterile Injectables With Exact SI-ence
4/16/2024
Sterile injectables present multiple hurdles on the path from early clinical phases to commercial. Learn how a partner with extensive capabilities and expertise can help streamline the path to market.
-
Extractables And Leachables Testing
4/9/2024
Learn how to navigate the extractables and leachables regulatory landscape and implement best practices for leachables analysis in your pharmaceutical development process.
-
Reducing Product Loss In The Biomanufacturing Cold Chain
3/25/2024
Traditional single-use bags are vulnerable to damage at multiple points in the cold chain. Learn about flexible containers that minimize the risk and bring strength and durability to your cold chain.
-
Selecting Container Closure Systems With Confidence: Lyophilization
3/7/2024
Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.
-
Safe Handling Of Monoclonal Antibodies: Best Practices
3/7/2024
Explore safety measures for handling mAbs in production in order to meet strict requirements that prevent contamination, product loss and exposure to cytotoxic agents or radioisotopes.
-
End-To-End Cold Chain Management: A Next-Generation Approach
2/26/2024
Three experts in cold chain management walk through the advantages of end-to-end platforms for bulk drug substance management.